• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p53功能的一个不同方面:肿瘤发生过程中免疫与炎症的调节

A Different Facet of p53 Function: Regulation of Immunity and Inflammation During Tumor Development.

作者信息

Shi Di, Jiang Peng

机构信息

School of Life Sciences, Tsinghua University, Beijing, China.

Tsinghua-Peking Center for Life Sciences, Beijing, China.

出版信息

Front Cell Dev Biol. 2021 Oct 18;9:762651. doi: 10.3389/fcell.2021.762651. eCollection 2021.

DOI:10.3389/fcell.2021.762651
PMID:34733856
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8558413/
Abstract

As a key transcription factor, the evolutionarily conserved tumor suppressor p53 (encoded by 53) plays a central role in response to various cellular stresses. A variety of biological processes are regulated by p53 such as cell cycle arrest, apoptosis, senescence and metabolism. Besides these well-known roles of p53, accumulating evidence show that p53 also regulates innate immune and adaptive immune responses. p53 influences the innate immune system by secreted factors that modulate macrophage function to suppress tumourigenesis. Dysfunction of p53 in cancer affects the activity and recruitment of T and myeloid cells, resulting in immune evasion. p53 can also activate key regulators in immune signaling pathways which support or impede tumor development. Hence, it seems that the tumor suppressor p53 exerts its tumor suppressive effect to a considerable extent by modulating the immune response. In this review, we concisely discuss the emerging connections between p53 and immune responses, and their impact on tumor progression. Understanding the role of p53 in regulation of immunity will help to developing more effective anti-tumor immunotherapies for patients with mutation or depletion.

摘要

作为一种关键的转录因子,进化上保守的肿瘤抑制因子p53(由TP53基因编码)在应对各种细胞应激时发挥着核心作用。p53调控多种生物学过程,如细胞周期阻滞、凋亡、衰老和代谢。除了这些p53的众所周知的作用外,越来越多的证据表明p53还调控先天性免疫和适应性免疫反应。p53通过分泌调节巨噬细胞功能以抑制肿瘤发生的因子来影响先天性免疫系统。癌症中p53功能失调会影响T细胞和髓样细胞的活性及募集,导致免疫逃逸。p53还可激活免疫信号通路中的关键调节因子,这些因子支持或阻碍肿瘤发展。因此,肿瘤抑制因子p53似乎在很大程度上通过调节免疫反应发挥其肿瘤抑制作用。在本综述中,我们简要讨论p53与免疫反应之间新出现的联系及其对肿瘤进展的影响。了解p53在免疫调节中的作用将有助于为有突变或缺失的患者开发更有效的抗肿瘤免疫疗法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/126a/8558413/ca8c461058af/fcell-09-762651-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/126a/8558413/3a7f3a2e7630/fcell-09-762651-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/126a/8558413/ca8c461058af/fcell-09-762651-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/126a/8558413/3a7f3a2e7630/fcell-09-762651-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/126a/8558413/ca8c461058af/fcell-09-762651-g002.jpg

相似文献

1
A Different Facet of p53 Function: Regulation of Immunity and Inflammation During Tumor Development.p53功能的一个不同方面:肿瘤发生过程中免疫与炎症的调节
Front Cell Dev Biol. 2021 Oct 18;9:762651. doi: 10.3389/fcell.2021.762651. eCollection 2021.
2
Immunomodulatory Function of the Tumor Suppressor p53 in Host Immune Response and the Tumor Microenvironment.肿瘤抑制因子p53在宿主免疫反应和肿瘤微环境中的免疫调节功能
Int J Mol Sci. 2016 Nov 19;17(11):1942. doi: 10.3390/ijms17111942.
3
Potential role of p53 deregulation in modulating immune responses in human malignancies: A paradigm to develop immunotherapy.p53 失调控在调节人类恶性肿瘤免疫反应中的潜在作用:开发免疫疗法的范例。
Cancer Lett. 2024 Apr 28;588:216766. doi: 10.1016/j.canlet.2024.216766. Epub 2024 Feb 24.
4
p53, cancer and the immune response.p53、癌症与免疫反应
J Cell Sci. 2020 Mar 6;133(5):jcs237453. doi: 10.1242/jcs.237453.
5
Local Activation of p53 in the Tumor Microenvironment Overcomes Immune Suppression and Enhances Antitumor Immunity.肿瘤微环境中p53的局部激活可克服免疫抑制并增强抗肿瘤免疫力。
Cancer Res. 2017 May 1;77(9):2292-2305. doi: 10.1158/0008-5472.CAN-16-2832. Epub 2017 Mar 9.
6
p53 mutation and deletion contribute to tumor immune evasion.p53突变和缺失有助于肿瘤免疫逃逸。
Front Genet. 2023 Feb 20;14:1088455. doi: 10.3389/fgene.2023.1088455. eCollection 2023.
7
Interactions between the tumor suppressor p53 and immune responses.肿瘤抑制因子 p53 与免疫反应的相互作用。
Curr Opin Oncol. 2013 Jan;25(1):85-92. doi: 10.1097/CCO.0b013e32835b6386.
8
The role of p53 in anti-tumor immunity and response to immunotherapy.p53在抗肿瘤免疫及免疫治疗反应中的作用。
Front Mol Biosci. 2023 Aug 1;10:1148389. doi: 10.3389/fmolb.2023.1148389. eCollection 2023.
9
The regulation of cellular metabolism by tumor suppressor p53.肿瘤抑制因子 p53 对细胞代谢的调节。
Cell Biosci. 2013 Feb 6;3(1):9. doi: 10.1186/2045-3701-3-9.
10
Emerging roles of p53 and other tumour-suppressor genes in immune regulation.p53及其他肿瘤抑制基因在免疫调节中的新作用。
Nat Rev Immunol. 2016 Dec;16(12):741-750. doi: 10.1038/nri.2016.99. Epub 2016 Sep 26.

引用本文的文献

1
Dissecting cross-lineage tumourigenesis under p53 inactivation through single-cell multi-omics and spatial transcriptomics.通过单细胞多组学和空间转录组学剖析p53失活状态下的跨谱系肿瘤发生
Clin Transl Med. 2025 Sep;15(9):e70461. doi: 10.1002/ctm2.70461.
2
The Multifaceted Role of p53 in Cancer Molecular Biology: Insights for Precision Diagnosis and Therapeutic Breakthroughs.p53在癌症分子生物学中的多面角色:精准诊断与治疗突破的见解
Biomolecules. 2025 Jul 27;15(8):1088. doi: 10.3390/biom15081088.
3
Cellular defense mechanisms against asbestos fibers.

本文引用的文献

1
The ubiquitin ligase MDM2 sustains STAT5 stability to control T cell-mediated antitumor immunity.泛素连接酶 MDM2 维持 STAT5 的稳定性以控制 T 细胞介导的抗肿瘤免疫。
Nat Immunol. 2021 Apr;22(4):460-470. doi: 10.1038/s41590-021-00888-3. Epub 2021 Mar 25.
2
Mutant p53 suppresses innate immune signaling to promote tumorigenesis.突变型 p53 抑制先天免疫信号转导以促进肿瘤发生。
Cancer Cell. 2021 Apr 12;39(4):494-508.e5. doi: 10.1016/j.ccell.2021.01.003. Epub 2021 Feb 4.
3
p53, cancer and the immune response.p53、癌症与免疫反应
细胞对石棉纤维的防御机制。
Front Public Health. 2025 May 14;13:1566473. doi: 10.3389/fpubh.2025.1566473. eCollection 2025.
4
Exploring the Genetic Orchestra of Cancer: The Interplay Between Oncogenes and Tumor-Suppressor Genes.探索癌症的基因交响乐:癌基因与肿瘤抑制基因之间的相互作用。
Cancers (Basel). 2025 Mar 24;17(7):1082. doi: 10.3390/cancers17071082.
5
is a metabolic checkpoint in triple-negative breast cancer: Insights from multiple omics analysis and experiments.是三阴性乳腺癌中的一个代谢检查点:来自多组学分析和实验的见解。
Mol Ther Oncol. 2025 Mar 7;33(2):200963. doi: 10.1016/j.omton.2025.200963. eCollection 2025 Jun 18.
6
p53: A player in the tumor microenvironment.p53:肿瘤微环境中的一个参与者。
Oncol Res. 2025 Mar 19;33(4):795-810. doi: 10.32604/or.2025.057317. eCollection 2025.
7
C1Q TPP1 macrophages promote colon cancer progression through SETD8-driven p53 methylation.C1Q TPP1巨噬细胞通过SETD8驱动的p53甲基化促进结肠癌进展。
Mol Cancer. 2025 Mar 31;24(1):102. doi: 10.1186/s12943-025-02293-y.
8
Wild-Type TP53 Predicts Poor Prognosis in Lower-Grade Glioma via TP53-CXCL14-GATA3 Axis.野生型TP53通过TP53-CXCL14-GATA3轴预测低级别胶质瘤的不良预后。
J Mol Neurosci. 2025 Mar 18;75(2):37. doi: 10.1007/s12031-025-02323-w.
9
Targeting deubiquitinating enzymes (DUBs) and ubiquitin pathway modulators to enhance host defense against bacterial infections.靶向去泛素化酶(DUBs)和泛素途径调节剂以增强宿主对细菌感染的防御能力。
bioRxiv. 2025 Jan 29:2025.01.27.635188. doi: 10.1101/2025.01.27.635188.
10
Restoration of the Tumor Suppressor Function of Y220C-Mutant p53 by Rezatapopt, a Small-Molecule Reactivator.小分子激活剂Rezatapopt恢复Y220C突变型p53的肿瘤抑制功能
Cancer Discov. 2025 Jun 3;15(6):1159-1179. doi: 10.1158/2159-8290.CD-24-1421.
J Cell Sci. 2020 Mar 6;133(5):jcs237453. doi: 10.1242/jcs.237453.
4
Cancer-Specific Loss of p53 Leads to a Modulation of Myeloid and T Cell Responses.肿瘤特异性 p53 缺失导致髓系和 T 细胞反应的调节。
Cell Rep. 2020 Jan 14;30(2):481-496.e6. doi: 10.1016/j.celrep.2019.12.028.
5
IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression.干扰素-γ诱导黑色素瘤中 PD-L1 的表达依赖于 p53 表达。
J Exp Clin Cancer Res. 2019 Sep 11;38(1):397. doi: 10.1186/s13046-019-1403-9.
6
Mechanisms of Resistance to Immune Checkpoint Blockade: Why Does Checkpoint Inhibitor Immunotherapy Not Work for All Patients?免疫检查点阻断的耐药机制:为何检查点抑制剂免疫疗法并非对所有患者都有效?
Am Soc Clin Oncol Educ Book. 2019 Jan;39:147-164. doi: 10.1200/EDBK_240837. Epub 2019 May 17.
7
cGAS in action: Expanding roles in immunity and inflammation.cGAS 在行动:在免疫和炎症中的作用不断扩大。
Science. 2019 Mar 8;363(6431). doi: 10.1126/science.aat8657.
8
Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers.新抗原筛查确定了上皮癌患者中广泛的TP53突变免疫原性。
J Clin Invest. 2019 Mar 1;129(3):1109-1114. doi: 10.1172/JCI123791. Epub 2019 Feb 4.
9
p53 mutants cooperate with HIF-1 in transcriptional regulation of extracellular matrix components to promote tumor progression.p53 突变体与 HIF-1 合作,对细胞外基质成分进行转录调控,促进肿瘤进展。
Proc Natl Acad Sci U S A. 2018 Nov 13;115(46):E10869-E10878. doi: 10.1073/pnas.1808314115. Epub 2018 Oct 31.
10
Role of p53 in the Regulation of the Inflammatory Tumor Microenvironment and Tumor Suppression.p53在炎症性肿瘤微环境调节及肿瘤抑制中的作用
Cancers (Basel). 2018 Jun 27;10(7):219. doi: 10.3390/cancers10070219.